The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Maraganore John since year 2005.
The trader's CIK number is 1180432.
At the time of the last reporting, Maraganore John was the Chief Executive Officer of Alnylam Pharmaceuticals, Inc. .
(stock ticker symbol ALNY).
See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-10-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 49,456 | 16.43 | 812,562 |
| 2019-10-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 49,456 | 79.68 | 3,940,505 |
| 2019-05-31 | AGIO | Agios Pharmaceuticals Inc | Option Ex | 1,400 | .00 | 0 |
| 2019-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 49,457 | 16.43 | 812,578 |
| 2019-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 49,457 | 70.00 | 3,461,990 |
| 2018-11-21 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 98,636 | 21.35 | 2,105,878 |
| 2018-09-11 | AGIO | Agios Pharmaceuticals Inc | Sale | 13,555 | 73.17 | 991,819 |
| 2018-09-12 | AGIO | Agios Pharmaceuticals Inc | Sale | 14,162 | 71.74 | 1,015,981 |
| 2018-07-25 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 50,000 | 21.35 | 1,067,500 |
| 2018-07-25 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 50,000 | 104.62 | 5,231,100 |
| 2017-12-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 1,587 | 63.00 | 99,981 |
| 2017-11-22 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 73,415 | 31.39 | 2,304,496 |
| 2017-11-22 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 73,415 | 131.35 | 9,643,060 |
| 2017-11-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 74,000 | 127.99 | 9,471,482 |
| 2017-11-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 74,000 | 31.39 | 2,322,860 |
| 2017-09-14 | BLUE | Bluebird Bio, Inc. | Option Ex | 18,868 | 2.09 | 39,434 |
| 2017-09-14 | BLUE | Bluebird Bio, Inc. | Sale | 18,868 | 131.50 | 2,481,236 |
| 2017-08-02 | BLUE | Bluebird Bio, Inc. | Sale | 2,754 | 96.74 | 266,424 |
| 2017-08-24 | BLUE | Bluebird Bio, Inc. | Option Ex | 13,839 | 2.09 | 28,923 |
| 2017-08-24 | BLUE | Bluebird Bio, Inc. | Sale | 11,085 | 95.72 | 1,061,100 |
| 2017-03-03 | BLUE | Bluebird Bio, Inc. | Option Ex | 13,839 | 3.22 | 44,616 |
| 2017-03-03 | BLUE | Bluebird Bio, Inc. | Sale | 13,839 | 85.02 | 1,176,647 |
| 2017-01-05 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 1,340 | 18.66 | 25,004 |
| 2016-12-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 30,151 | 22.75 | 685,935 |
| 2016-10-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 7,540 | 12.88 | 97,115 |
| 2016-07-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-07-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,075 | 22.75 | 342,956 |
| 2016-07-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,076 | 64.14 | 967,004 |
| 2016-07-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,075 | 65.28 | 984,141 |
| 2016-04-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,075 | 67.81 | 1,022,235 |
| 2016-04-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,076 | 67.91 | 1,023,796 |
| 2016-04-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,075 | 22.75 | 342,956 |
| 2016-04-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-01-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-01-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 15,076 | 22.75 | 342,979 |
| 2016-01-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,076 | 74.49 | 1,122,966 |
| 2016-01-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 15,076 | 70.50 | 1,062,903 |
| 2015-12-02 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 58,689 | 104.99 | 6,161,523 |
| 2015-12-02 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 58,689 | 13.12 | 769,999 |
| 2015-11-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 69,254 | 10.11 | 700,157 |
| 2015-11-20 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 58,690 | 103.14 | 6,053,580 |
| 2015-01-26 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 10,000 | 95.00 | 950,000 |
| 2014-12-19 | BLUE | Bluebird Bio, Inc. | Buy | 2,352 | 85.00 | 199,920 |
| 2014-12-16 | AGIO | Agios Pharmaceuticals Inc | Buy | 1,806 | 110.75 | 200,014 |
| 2014-12-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 8,205 | 9.14 | 74,993 |
| 2014-09-18 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 78.67 | 4,471,301 |
| 2014-09-17 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 76.55 | 4,350,529 |
| 2014-09-18 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 7.47 | 424,549 |
| 2014-09-17 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 7.47 | 424,549 |
| 2014-07-14 | BLUE | Bluebird Bio, Inc. | Buy | 2,941 | 34.00 | 99,994 |
| 2014-06-25 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 7.47 | 424,549 |
| 2014-06-26 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 7.47 | 424,549 |
| 2014-06-25 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 66.08 | 3,755,306 |
| 2014-06-26 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 65.59 | 3,727,628 |
| 2014-06-23 | AGIO | Agios Pharmaceuticals Inc | Buy | 2,300 | 43.98 | 101,154 |
| 2014-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 7.12 | 404,942 |
| 2014-05-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 56,834 | 6.78 | 385,334 |
| 2014-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 56.39 | 3,204,755 |
| 2014-05-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 56,834 | 57.42 | 3,263,635 |
| 2014-04-29 | AGIO | Agios Pharmaceuticals Inc | Buy | 2,250 | 44.00 | 99,000 |
| 2014-04-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 28,707 | 19.03 | 546,294 |
| 2013-07-24 | AGIO | Agios Pharmaceuticals Inc | Buy | 8,333 | 18.00 | 149,994 |
| 2014-02-03 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 46,331 | 6.78 | 314,124 |
| 2013-10-10 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 12,665 | 6.78 | 85,868 |
| 2013-09-11 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 58,947 | 56.26 | 3,316,122 |
| 2013-09-11 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 58,947 | .95 | 55,999 |
| 2013-08-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 60,000 | 48.92 | 2,935,140 |
| 2013-08-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 60,000 | .95 | 57,000 |
| 2013-07-10 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 60,000 | .95 | 57,000 |
| 2013-07-10 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 60,000 | 37.11 | 2,226,840 |
| 2013-02-28 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 28,503 | 23.50 | 669,906 |
| 2013-02-27 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 30,000 | 23.47 | 704,010 |
| 2012-12-19 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 18,617 | .47 | 8,843 |
| 2012-02-21 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 5,581 | 10.75 | 59,995 |
| 2012-01-09 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 1,134 | 8.81 | 9,995 |
| 2011-12-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 1,397 | 7.16 | 9,995 |
| 2011-11-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 1,411 | 7.08 | 9,996 |
| 2011-10-11 | ALNY | Alnylam Pharmaceuticals, Inc. | Buy | 1,480 | 6.75 | 9,988 |
| 2010-08-17 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 50,000 | .47 | 23,750 |
| 2009-06-16 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 40,000 | .47 | 19,000 |
| 2009-06-17 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 40,000 | .47 | 19,000 |
| 2009-06-16 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 40,000 | 21.80 | 871,800 |
| 2009-06-18 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 40,000 | .47 | 19,000 |
| 2009-06-17 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 40,000 | 21.40 | 855,840 |
| 2009-06-18 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 40,000 | 21.37 | 854,640 |
| 2008-08-18 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 750 | .47 | 356 |
| 2008-08-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 37,500 | 34.23 | 1,283,512 |
| 2008-08-13 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 37,500 | 33.95 | 1,272,975 |
| 2008-08-14 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2008-08-13 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2008-06-30 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 3,000 | .47 | 1,425 |
| 2007-06-29 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 18,722 | 15.40 | 288,243 |
| 2007-06-29 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2007-06-28 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 17,431 | 16.11 | 280,778 |
| 2007-06-28 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 20,069 | 15.92 | 319,498 |
| 2007-06-28 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2007-06-29 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 1,689 | 16.20 | 27,366 |
| 2007-06-29 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 17,089 | 15.83 | 270,553 |
| 2006-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2006-05-15 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 41,635 | 15.07 | 627,647 |
| 2006-05-16 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 1,000 | 15.05 | 15,050 |
| 2006-05-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Option Ex | 37,500 | .47 | 17,812 |
| 2006-05-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 28,313 | 15.20 | 430,300 |
| 2006-05-12 | ALNY | Alnylam Pharmaceuticals, Inc. | Sale | 13,322 | 15.72 | 209,395 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Maraganore John (Chief Executive Officer of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.